Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleTOXICOLOGY

Inhibition of Mitochondrial Hydrogen Peroxide Production by Lipophilic Metalloporphyrins

Pablo R. Castello, Derek A. Drechsel, Brian J. Day and Manisha Patel
Journal of Pharmacology and Experimental Therapeutics March 2008, 324 (3) 970-976; DOI: https://doi.org/10.1124/jpet.107.132134
Pablo R. Castello
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek A. Drechsel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian J. Day
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manisha Patel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Many studies have established a role for oxidative stress and mitochondrial dysfunction as an important mechanism in the pathogenesis of neuronal disorders. Metalloporphyrins are a class of catalytic antioxidants that are capable of detoxifying a wide range of reactive oxygen species. The AEOL112 series of glyoxylate metalloporphyrins were designed with increased lipid solubility for better oral bioavailability and penetration of the blood-brain barrier. The goal of this study was to develop an in vitro assay using rat brain mitochondria to reliably detect endogenously released hydrogen peroxide (H2O2) and identify glyoxylate metalloporphyrins based on rank order of potency for removal of physiologically relevant H2O2. A polarographic method was established for the sensitive, accurate, and reproducible detection of low levels of H2O2. The assay identified several potent glyoxylate metalloporphyrins with H2O2 scavenging potencies (IC50) in the nanomolar range. These results provide a simplified in vitro model system to detect physiologically generated mitochondrial H2O2 as a screening tool to predict the biological efficacy of potential therapeutic entities.

Footnotes

  • This work was supported by NINDS, National Institutes of Health Grants RO1NS045748, R01NS039587, and R21NS053548 (to M.P.) and Aeolus Pharmaceuticals (to M.P. and B.J.D.).

  • B.J.D. is a consultant for and holds equity in Aeolus Pharmaceuticals, which is developing catalytic antioxidants as therapeutic agents.

  • Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.

  • doi:10.1124/jpet.107.132134.

  • ABBREVIATIONS: ROS, reactive oxygen species; MnTBAP, manganese (III) meso-tetrakis (4-carboxyphenyl or benzoic acid) porphyrin; AEOL10150, manganese (III) meso-tetrakis (N,N′-diethylimidazolium-2-yl) porphyrin; AEOL10113, manganese (III) meso-tetrakis (N-ethyl pyridinium-2-yl) porphyrin; PQ2+, paraquat; LDH, lactate dehydrogenase; COX, cytochrome c oxidase; DMSO, dimethyl sulfoxide; HRP, horseradish peroxidase; SOD, superoxide dismutase; TBA, thiobarbituric acid; TBARS, thiobarbituric acid reactive species; MDA, malondialdehyde; MnTE-2-PyP, manganese tetrakis-(N-ethyl-2-pyridyl) porphyrin.

  • ↵1 Current affiliation: Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, Colorado.

    • Received September 27, 2007.
    • Accepted December 5, 2007.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 382 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 382, Issue 1
1 Jul 2022
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Inhibition of Mitochondrial Hydrogen Peroxide Production by Lipophilic Metalloporphyrins
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleTOXICOLOGY

Inhibition of Mitochondrial Hydrogen Peroxide Production by Lipophilic Metalloporphyrins

Pablo R. Castello, Derek A. Drechsel, Brian J. Day and Manisha Patel
Journal of Pharmacology and Experimental Therapeutics March 1, 2008, 324 (3) 970-976; DOI: https://doi.org/10.1124/jpet.107.132134

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleTOXICOLOGY

Inhibition of Mitochondrial Hydrogen Peroxide Production by Lipophilic Metalloporphyrins

Pablo R. Castello, Derek A. Drechsel, Brian J. Day and Manisha Patel
Journal of Pharmacology and Experimental Therapeutics March 1, 2008, 324 (3) 970-976; DOI: https://doi.org/10.1124/jpet.107.132134
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Nafamostat is a potent human diamine oxidase inhibitor
  • Chemoproteomics Investigation of Testicular Toxicity with BTK Inhibitor
  • Bosentan Alters Bile Salt Disposition
Show more Toxicology

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics